Cargando…
Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608641/ https://www.ncbi.nlm.nih.gov/pubmed/36310599 http://dx.doi.org/10.3389/fmolb.2022.1046852 |
_version_ | 1784818822803357696 |
---|---|
author | Park, Chun Gwon Lee, Wonhwa Kim, Dong-Hyun Li, Fangyuan Park, Wooram |
author_facet | Park, Chun Gwon Lee, Wonhwa Kim, Dong-Hyun Li, Fangyuan Park, Wooram |
author_sort | Park, Chun Gwon |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9608641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96086412022-10-28 Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies Park, Chun Gwon Lee, Wonhwa Kim, Dong-Hyun Li, Fangyuan Park, Wooram Front Mol Biosci Molecular Biosciences Frontiers Media S.A. 2022-10-13 /pmc/articles/PMC9608641/ /pubmed/36310599 http://dx.doi.org/10.3389/fmolb.2022.1046852 Text en Copyright © 2022 Park, Lee, Kim, Li and Park. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Park, Chun Gwon Lee, Wonhwa Kim, Dong-Hyun Li, Fangyuan Park, Wooram Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies |
title | Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies |
title_full | Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies |
title_fullStr | Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies |
title_full_unstemmed | Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies |
title_short | Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies |
title_sort | corrigendum: editorial: advanced nanotechnology for reactive oxygen species‐mediated therapies |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608641/ https://www.ncbi.nlm.nih.gov/pubmed/36310599 http://dx.doi.org/10.3389/fmolb.2022.1046852 |
work_keys_str_mv | AT parkchungwon corrigendumeditorialadvancednanotechnologyforreactiveoxygenspeciesmediatedtherapies AT leewonhwa corrigendumeditorialadvancednanotechnologyforreactiveoxygenspeciesmediatedtherapies AT kimdonghyun corrigendumeditorialadvancednanotechnologyforreactiveoxygenspeciesmediatedtherapies AT lifangyuan corrigendumeditorialadvancednanotechnologyforreactiveoxygenspeciesmediatedtherapies AT parkwooram corrigendumeditorialadvancednanotechnologyforreactiveoxygenspeciesmediatedtherapies |